Total Payments
$53,779
2024 Payments
$4,587
Companies
24
Transactions
161
Medicare Patients
6,408
Medicare Billing
$982,352
Payment Breakdown by Category
Research$32,294 (60.0%)
Travel$13,413 (24.9%)
Consulting$4,000 (7.4%)
Food & Beverage$3,990 (7.4%)
Education$80.78 (0.2%)
Gifts$1.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $32,294 | 6 | 60.0% |
| Travel and Lodging | $13,413 | 16 | 24.9% |
| Consulting Fee | $4,000 | 1 | 7.4% |
| Food and Beverage | $3,990 | 132 | 7.4% |
| Education | $80.78 | 5 | 0.2% |
| Gift | $1.77 | 1 | 0.0% |
Payments by Type
Research
$32,294
6 transactions
General
$21,485
155 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Keryx Biopharmaceuticals, Inc. | $30,953 | 9 | $0 (2018) |
| AstraZeneca AB | $12,011 | 15 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $5,125 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,632 | 14 | $0 (2024) |
| Eli Lilly and Company | $1,391 | 1 | $0 (2024) |
| NXSTAGE MEDICAL, INC. | $780.10 | 21 | $0 (2024) |
| Amgen Inc. | $534.08 | 24 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $294.38 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $273.74 | 14 | $0 (2021) |
| OPKO Pharmaceuticals, LLC | $217.14 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,587 | 40 | Bayer Healthcare Pharmaceuticals Inc. ($1,611) |
| 2023 | $44.06 | 2 | Amgen Inc. ($27.67) |
| 2022 | $265.32 | 9 | NxStage Medical, Inc. ($111.42) |
| 2021 | $278.48 | 16 | Amgen Inc. ($34.77) |
| 2020 | $192.17 | 10 | Otsuka America Pharmaceutical, Inc. ($109.17) |
| 2019 | $507.31 | 24 | Amgen Inc. ($222.05) |
| 2018 | $15,728 | 39 | AstraZeneca AB ($10,969) |
| 2017 | $32,177 | 21 | Keryx Biopharmaceuticals, Inc. ($30,905) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $109.25 | General |
| Category: Nephrology | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $115.49 | General |
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $49.05 | General |
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $629.95 | General |
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $166.95 | General |
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $89.36 | General |
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $68.74 | General |
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $41.24 | General |
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $39.99 | General |
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $34.37 | General |
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $166.95 | General |
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $105.86 | General |
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $78.70 | General |
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $24.75 | General |
| 10/08/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $115.82 | General |
| Category: Nephrology | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Eli Lilly and Company | — | — | In-kind items and services | $1,391.13 | Research |
| Study: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF VOLENRELAXIN IN ADULTS WITH CHRONIC KIDNEY DISEASE | ||||||
| 09/03/2024 | Fresenius USA Marketing, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $85.23 | General |
| Category: Nephrology | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.06 | General |
| 08/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.08 | General |
| 07/30/2024 | Fresenius USA Marketing, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $74.27 | General |
| Category: Nephrology | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $165.50 | General |
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | Cash or cash equivalent | $53.03 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Compass | Keryx Biopharmaceuticals, Inc. | $30,903 | 5 |
| A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF VOLENRELAXIN IN ADULTS WITH CHRONIC KIDNEY DISEASE | Eli Lilly and Company | $1,391 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,214 | 3,224 | $496,559 | $215,826 |
| 2022 | 25 | 1,530 | 3,570 | $508,925 | $217,280 |
| 2021 | 29 | 2,003 | 4,027 | $604,713 | $276,619 |
| 2020 | 33 | 1,661 | 3,409 | $592,213 | $272,627 |
Total Patients
6,408
Total Services
14,230
Medicare Billing
$982,352
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 52 | 366 | $190,320 | $100,014 | 52.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 31 | 206 | $107,120 | $47,120 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 297 | $62,851 | $18,951 | 30.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 37 | 54 | $28,080 | $12,338 | 43.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 189 | $26,997 | $10,947 | 40.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 84 | $17,291 | $6,395 | 37.0% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 19 | 550 | $15,395 | $3,174 | 20.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 130 | 358 | $5,370 | $2,991 | 55.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $5,694 | $2,916 | 51.2% |
| 80069 | Kidney function blood test panel | Office | 2023 | 121 | 316 | $8,229 | $2,675 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,086 | $2,386 | 39.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 101 | 172 | $5,160 | $865.16 | 16.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $2,408 | $691.46 | 28.7% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 15 | 17 | $2,105 | $687.65 | 32.7% |
| 84156 | Total protein level, urine | Office | 2023 | 102 | 176 | $1,938 | $627.12 | 32.4% |
| 83735 | Magnesium level | Office | 2023 | 57 | 83 | $1,668 | $545.31 | 32.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 26 | 37 | $1,513 | $470.16 | 31.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 38 | 61 | $3,050 | $451.39 | 14.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 14 | 14 | $1,243 | $406.14 | 32.7% |
| 83550 | Iron binding capacity | Office | 2023 | 29 | 42 | $1,101 | $344.44 | 31.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 34 | $1,407 | $339.84 | 24.2% |
| 83540 | Iron level | Office | 2023 | 29 | 42 | $815.22 | $254.84 | 31.3% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 26 | 41 | $291.51 | $95.12 | 32.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 17 | 24 | $228.24 | $74.64 | 32.7% |
| 84100 | Phosphate level | Office | 2023 | 12 | 14 | $199.08 | $65.10 | 32.7% |
About Dr. Manuel Montero, M.D
Dr. Manuel Montero, M.D is a Nephrology healthcare provider based in New Bern, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114929346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Montero, M.D has received a total of $53,779 in payments from pharmaceutical and medical device companies, with $4,587 received in 2024. These payments were reported across 161 transactions from 24 companies. The most common payment nature is "" ($32,294).
As a Medicare-enrolled provider, Montero has provided services to 6,408 Medicare beneficiaries, totaling 14,230 services with total Medicare billing of $982,352. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location New Bern, NC
- Active Since 06/01/2005
- Last Updated 12/20/2011
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1114929346
Products in Payments
- Auryxia (Drug) $30,953
- FARXIGA (Drug) $16,131
- Parsabiv (Biological) $415.65
- NXSTAGE SYSTEM ONE (Device) $384.57
- System One (Device) $366.60
- Rayaldee (Drug) $192.21
- JYNARQUE (Drug) $142.32
- SAMSCA (Drug) $131.42
- Veltassa (Drug) $114.65
- LIBERTY SELECT CYCLER (Device) $111.42
- Velphoro (Drug) $109.90
- BENLYSTA (Biological) $89.09
- KRYSTEXXA (Biological) $77.22
- SYSTEM ONE (Device) $77.01
- Parsabiv (Drug) $62.44
- INJECTAFER (Drug) $49.96
- LUPKYNIS (Drug) $33.72
- FABRY-DISEASE (Drug) $32.40
- AURYXIA (Drug) $30.24
- TARPEYO (Drug) $26.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in New Bern
Joseph Coladonato, M.d, M.D
Nephrology — Payments: $37,404
Nephrology $37,404
Nathan Saucier, Md, MD
Nephrology — Payments: $22,584
Nephrology $22,584
Stuart Jennings, M.d, M.D
Nephrology — Payments: $13,221
Nephrology $13,221
Thomas Burkart, M.d, M.D
Nephrology — Payments: $979.95
Nephrology $979.95
Walter Newman, M.d, M.D
Nephrology — Payments: $725.55
Nephrology $725.55